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Mouse resident macrophages are potent sources of arachidonic acid (20:4) 1 metab- 
olites generated via both the cyclooxygenase and lipoxygenase pathways  (1-5). The 
phospholipids  of this  cell  are  highly  enriched  with  20:4,  and  upon  appropriate 
membrane stimulation, up to 50% of endogenous 20:4 is released and metabolized to 
a mixture of prostaglandins, hydroxy-eicosatetraenoic acids (HETEs), and leukotriene 
C, a  slow-reacting substance of anaphylaxis (2-3). Resident macrophages also have 
the capacity to quantitatively convert exogenously supplied 20:4 in the absence of a 
stimulus to a qualitatively different mixture of oxygenated products (4). The overall 
proportion of lipoxygenase products is enhanced compared to the metabolites gener- 
ated from endogenous 20:4, but the formation of leukotriene C is diminished. Finally, 
the metabolites produced from either endogenous or exogenous sources of 20:4 are 
altered by the activation state of the macrophage (4-5). 
In this report, we show that resting macrophages have a  considerable capacity to 
both incorporate mono-HETEs into cell phospholipid and metabolize these hydroxy 
acids.  The  major  metabolite  generated  from  5-HETE  is  a  conjugated  triene,  a 
structural  characteristic  of certain  20:4  derivatives with  potent  biologic activities. 
These two metabolic fates of mono-HETEs were altered in macrophages elicited with 
Corynebacterium parvum. 
Materials and Methods 
Mice.  Male  and  female ICR  (CD-1)  mice  (20-25  g)  were  purchased  from  the  Trudeau 
Institute, Saranac Lake, NY. 
Human  Peripheral Blood Components.  Leukocyte concentrates  were obtained  from The  New 
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1 Abbreviations used in thispaper: A23187, calcium ionophore A23187; a-MEM, minimal essential medium/ 
alpha modified; 20:4, arachidonic acid; [SH]20:4, [5,6,8,9,11,12,13,15-SH]20:4; EDTA, ethylenediamiuetet- 
raacetic acid;  FCS, fetal calf serum;  HERE, hydroxy-eicosatetraenoic  acid;  15-HETE,  15-hydroxy-5,8,- 
11,13-eicosatetraenoic  acid;  12-HETE,  12-hydroxy-5,8,10,14-eicosatet raenoic acid;  5-HETE, 5-hydroxy- 
6,8,11,14-eicosatetraenoic  acid; 5(S), 12(S)-di-HETE,  5 (S), 12(S)-dihydroxy-6,8,10,14-eicosatetraenoic  acid; 
HPLC,  high pressure  liquid chromatography;  leukotrlene B4, 5(S),  12(R)-dihydroxy-6,8,10,t4-cis,  trans, 
tram, cis-eicosatetraenoic acid; leukotriene C, 5(S)-hydroxy-6(R)-S-y-glutamylcysteinylglycyl-7,9,1  l,i4-ei- 
cosatetraenoie  acid; PBS, phosphate-buffered saline; PD, calcium- and magnesium-free phosphate-buffered 
saline;  PGFa, prostaglandin E2; PGF2~, prostaglandin F2a; 6-keto PGFI,, 6-keto prostaglandin Fla; TXB2, 
thromboxane B2. 
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York Blood  Center, New York,  NY.  Platelets were  isolated from whole blood obtained from 
healthy human volunteers after informed consent and collected into a final concentration of 7% 
(vol/vol) of 77 mM EDTA as anticoagulant. 
Materials.  Minimal essential medium/alpha modified (a-MEM, KC Biological Inc., Lenexa, 
KS) supplemented with  100 U/ml penicillin G and 100/lg/ml streptomycin (Gibco Labora- 
tories,  Grand Island Biological  Co.,  Grand Island, NY)  was  used throughout for culture of 
mouse peritoneal cells.  Formalin-killed C. parvum (Coparvax)  was  obtained from  Burroughs 
Wellcome Co., Research Triangle Park, NC. [5,6,8,9,11,12,14,15-aH]20:4  ([3H]20:4) (78.2 Ci/ 
mmol sp act) was purchased from New England Nuclear, Boston, MA, and unlabeled 20:4 was 
obtained from Nu-Chek-Prep, Inc., Elysian, MN.  [5,8,9,11,12,14,15-3H]  6-keto prostaglandin 
F~,  [5,6,8,9,11,12,14,15-aH]  thromboxane B2,  [5,6,8,9,11,12,14,15-aH]  prostaglandin F2a, and 
[5,6,8,11,12,14,15-3H]  prostaglandin E2 were all purchased  from New  England Nuclear (all 
120-200 Ci/mmol sp act). Hydrofluor was obtained from National Diagnostics, Inc., Advanced 
Applications Institute Inc., Somerville, NJ.  Dextran 6%  (wt/vol) in 0.9% NaC1 was obtained 
from  Abbott  Diagnostics, Diagnostic Products,  North  Chicago,  IL,  and  Ficoll-Paque was 
purchased from Pharmacia Fine Chemicals, Div. of Pharmacia Inc., Piscataway, NJ. Calcium 
ionophore A23187  was obtained from Calbiochem-Behring Corp., San Diego,  CA.  Soybean 
lipoxidase type IV was obtained from Sigma Chemical Co., St. Louis, MO. Silica gel H  plates 
were  purchased from Analtech, Inc., Newark, DE, and Redi-Coat-2D plates were purchased 
from Supelco, Inc., Bellefonte,  PA. High pressure liquid chromatography (HPLC) columns 4.6- 
mm X 25-cm of ultrasphere C-18 were obtained from Beckman Instruments, Inc., Fullerton, 
CA. HPLC solvents were either HPLC grade or distilled before use. Zymosan was purchased 
from ICN K&K Laboratories Inc., Plainview, NY, and trypan blue 0.4% in 0.9% NaCI (wt/vol) 
was purchased from Gibco Laboratories. 
Macrophage Cultures.  Primary cultures of peritoneal macrophages  were  established  from 
resident cells of.male and female ICR (CD-1) mice, as previously described (1). Approximately 
8 x  10  s peritoneal lavage cells suspended in 1 ml of c~-MEM containing 10% fetal calf serum 
(FCS) were added to 35-mm Diam plastic culture dishes. After 2 h at 37°C in 5% CO2/95% air, 
cultures were washed three times in calcium- and magnesium-free phosphate-buffered saline 
(PD) to remove nonadherent cells and incubated overnight (16 h) in fresh c~-MEM containing 
10% FCS. 
C. parvum-elicited  peritoneal macrophages were obtained from mice injected intraperitoneally 
with  1.4  mg  of  formalin-killed C.  parvum 11-14  d  before  harvest.  Primary  cultures  were 
established as described for resident macrophages. 
Metabolism of Exogenously Supplied 20.'4 or 20:4 Oxygenated Metabolites.  At the end of the initial 
16-h incubation period, macrophage cultures were placed on ice, washed three times with cold 
PD, and overlaid with 1 ml of fresh c~-MEM without serum containing  the appropriate quantity 
of 20:4 or oxygenated 20:4 metabolite to be tested, including (a) 0.5 pCi of [3H]20:4 (6.4 nM) 
or 0.5/.tCi of [3H]20:4 and the indicated concentration of unlabeled 20:4;  (b)  mono-HETEs 
(15-,  12-, or  5-HETE);  and  (c)  cyclooxygenase products of 20:4  [6-keto  prostaglandin Ft, 
(6-keto  PGF1,), thromboxane B2  (TXB2),  prostaglandin F2~  (PGF2,), and prostaglandin E2 
(PGE2)]. 20:4 or each 20:4-derived product was dissolved  in a quantity of ethanol sufficient to 
make the  final ethanol concentration in the incubation medium 0.5%. Control incubations 
always contained equal amounts of ethanol. 
After  incubation for  the  indicated times  at  37°C  under 5%  COJ95%  air,  media  were 
removed  and  maintained on  ice  under an  atmosphere  of nitrogen. 20:4  metabolites were 
extracted from culture media after a modification of the procedure described by Unger et al. 
(6), as  previously described (4). In brief,  1 vol of absolute ethanol was  added,  the  mixture 
acidified with formic acid (final pH ~3), and the media extracted twice with  1 vol each of 
chloroform. The combined chloroform phases were dried completely under a stream of nitrogen 
and finally suspended in 400/d of the appropriate starting buffer for HPLC. 
Routinely, the kinetics of uptake for each 3H-labeled compound were measured in medium 
aliquots taken from triplicate or quadruplicate cultures. At the end of the incubation period, 
the cultures were  washed twice with PD and scraped into 1 ml of PD. The amount of cell- 
associated compound was calculated as the percent radioactivity found in cell  lysates  of the 
total recovered in the sum of radiolabel in medium plus cell lysates. N.  A.  PAWLOWSKI, W. A.  SCOTT,  M.  ANDREACH, AND Z.  A. COHN  1655 
Cell lipids were immediately extracted at 4°C, following the procedure of Bligh and Dyer 
(7). Individual phospholipids were separated by two-dimensional thin layer chromatography 
(1) on plates of silica gel. The organic phase of cell extracts was concentrated under nitrogen, 
spotted on plates, and overlaid with 0.1 ~mol of carrier lipid (nonradioactive) extracted from 
the macrophage-like cell line J774. Chromatograms were developed in the first dimension with 
chloroform/methanol/ammonium  hydroxide (65:35:5,  vol/vol/vol) and in the second dimen- 
sion with chloroform/acetone/methanol/acetic  acid/water (30:40:10:10:5, voI/vol/vol/vol/vol) 
(8). Lipid-containing  regions were visualized by a brief exposure of plates to iodine vapors and 
were  scraped  into scintillation vials.  Radioactivity was determined in Hydrofluor after  the 
addition of water (1 ml). 
Determination of Cell  Viability  and  Phagocytic Capacity.  After an  initial  16-h  cultivation in 
a-MEM with  10% FCS, macrophage monolayers on glass coverslips  were incubated for  2 h 
with each mono-HETE in 0t-MEM  or ot-MEM  alone under serumless conditions. Duplicate 
coverslips  were  immediately assessed  for  viability by trypan blue exclusion and phagocytic 
capacity by ingestion of zymosan, as previously described (1). 
HPLC.  All HPLC analyses were performed using columns (4.6-mm X 25-cm) of ultrasphere 
C-18 at a flow rate of 1 ml/min. Fractions of 1 ml were collected.  Fraction contents or aliquots 
were  dried  under a  stream  of air,  and  radioactivity was  measured  by  liquid scintillation 
counting. The mutual separation of cyclooxygenase products and di- and tri-HETEs, mono- 
HETEs, and unreacted 20:4 was achieved using the buffer system described by Borgeat and 
Samuelsson (9-10). The columns were eluted isocratically with 60-80 ml of methanol/water/ 
acetic acid (75:25:0.01,  vol/vol/vol) followed by 40 ml of methanol/acetic acid (100:0.01, vol/ 
vol). This combination of eluting solvents is referred to as solvent system 1. 
Appropriate fractions of the polar metabolites of the mono-HETEs compounds separated 
using solvent system  1 were  pooled, dried under reduced pressure,  and rechromatographed 
using solvent system 2 (60 ml of methanol/water/acetic acid [65:35:0.1,  vol/vol/vol, pH 5.4, 
with  NH4OH]  followed  by 40  ml of methanol/acetic acid  [100:0.01,  vol/vol]). Ultraviolet 
absorption spectra of the major polar metabolites of each mono-HETE tested were recorded in 
the first eluting buffer for solvent system 2. 
HPLC analyses of cyclooxygenase products recovered in medium extracts were performed 
using solvent system 3 under otherwise identical chromatographic conditions (4). The initial 
buffer consisted of water/acetonitrile/benzene/acetic  acid (76.7:23.0:0.2:0.1,  vol/vol/vol/vol) 
(11) for  100 min, followed by methanol/acetic acid (100:0.01, vol/vol) for 40 min. 
Preparation of 5-,  12-, and  15oHETEs.  5-  and  12-HETEs were  prepared  as  described by 
Borgeat and Samuelsson (9,  12-13).  Human neutrophils used for the preparation of 5-HETE 
were isolated from leukocyte concentrates by sequential dextran sedimentation and gradient 
separation on Ficoll-Paque according to established methods (14). Contaminating  erythrocytes 
were  eliminated by hypotonic lysis. Suspensions of neutrophils thus prepared were 95-98% 
pure.  12-HETE  was  generated  using human  platelets  isolated  from  platelet-rich  plasma 
obtained by centrifuging anticoagulated whole blood at 120 g at room temperature for 15 min. 
Platelets were  then isolated from platelet-rich plasma by centrifuging at  1,100 g for  15 min, 
washing twice with PD, and final resuspension in phosphate-buffered saline (PBS) containing 
calcium and magnesium at 37°C. 
Human neutrophils (30-40 ×  106/ml) or platelets (the derivative of 100 ml whole blood in 
25 ml final buffer)  suspended in PBS were incubated with 1 ~Ci/ml [3H]20:4 and 10 ~g/ml of 
A23187  at  37°C  under an  atmosphere of 5%  CO2/95%  air for  15  min. The  reaction was 
terminated by the addition of 1.5 vol of cold methanol, and extraction using diethy| ether was 
performed as described by Borgeat and Samuelsson (9). Whole extracts were dried to nil under 
nitrogen and subjected to silicic acid chromatography, also as described (12). Respective silicic 
acid column fractions containing mono-HETEs derived from either the neutrophil or platelet 
preparations were subjected to HPLC using solvent system 1 for final purification of 5- and 12- 
HETEs. 
15-HETE was generated by incubating an appropriate mixture of [3H]20:4 and unlabeled 
20:4 with soybean lipoxidase under the conditions described by Funk et al.  (15). In brief, 0.9 
×  10  -3 M  20:4 in 0.047  M  borate buffer (pH  9)  containing 3,000  U/ml of lipoxidase was 
incubated under an atmosphere of 95% 02 at  20°C for 5 min. The reaction products were 1656  MACROPHAGE  HYDROXY-EICOSATETRAENOIC  ACID METABOLISM 
extracted  as described  for the extraction of oxygenated metabolites of 20:4 from incubation 
media described above. After reduction with  triphenylphosphine  (16), the reaction products 
were partially purified by thin layer chromatography on heat-activated (120°C, 2 h) silica  gel 
H  plates  in  hexane/ethyl  acetate/acetic  acid  (1:1:0.005,  vol/vol/vol).  The  major band  of 
radioactivity was eluted from the plates and further purified by HPLC in solvent system 1. 
Each of the three mono-HETEs generated by these methods was separable by HPLC using 
solvent system 1. Typical elution times under the specified  conditions were 34-35, 38-39, and 
45-47 min for 15-, 12-, and  5-HETEs, respectively.  The 6-1actone  of 5-HETE was found to 
elute at 55-65 min. 
All purified mono-HETE preparations were quantified by measuring the optical density in 
methanol at 235 nm (E =  30,500  [9]) and were stored in chloroform/methanol (2:1, vol/vol) at 
-20°C under nitrogen until used. 
Results 
Time-Course of Exogenous 20:4 Metabolism.  In a  previous report  (4), we found that, 
in  the  absence of a  stimulus,  macrophages  maintained  in  serum-free  medium  both 
rapidly incorporate exogenously supplied 20:4 into cellular lipids and metabolize the 
fatty acid to more polar metabolites. Over a wide concentration range (10 nM-1/LM), 
uptake  was found to plateau  after  10 min. Thereafter,  ~30%  of the added  [all]20:4 
remained  cell-associated,  and  70%  was  found  in  the  medium  (4).  Fig.  1 shows  the 
kinetics of exogenously supplied 20:4 conversion to polar metabolites.  After 5 min of 
incubation,  70% of the radiolabel remaining in the culture medium was metabolized. 
Greater than 90% conversion was evident by 60 min.  Similar kinetics were observed 
when  the  20:4 concentration  was varied  from 6.4 nM  to  1 ftM.  These observations 
suggest  that  the  production  of oxygenated  metabolites  from  exogenously  supplied 
20:4 is significantly more rapid  than that  from endogenous 20:4 released  in response 
to specific stimuli  (1). 
Fig.  1 also shows that under these conditions, mono-HETEs represent a major class 
of metabolites  whose proportions  are  found to decrease as a  function of incubation 
time.  Mono-HETEs  were  36.7%,  26.1%,  and  11.9%  of the  total  20:4  metabolites 
recovered  from  the  incubation  medium  at  5,  10,  and  60  rain,  respectively.  In 
experiments such as that illustrated  in Fig.  1, the mono-HETE proportion of the total 
metabolites  decreased  threefold  to fourfold over the  5-60  min  incubation  interval. 
Concomitant  with  this  decrease  in  mono-HETEs  was  an  increase  in  more  polar 
metabolites eluting in fractions 4-25 in solvent system  1 (Fig.  1). 
The decrease in the proportion of mono-HETEs recovered from the medium over 
time was postulated to result  from additional  metabolic events. 
Metabolism of 15-,  12-, and 5-HETEs.  The metabolic  fate of exogenously supplied 
mono-HETEs was directly examined by incubating resting macrophage cultures with 
radiolabeled  15-,  12-, and 5-HETEs (final concentrations,  1/~M). As shown in Fig. 2, 
each compound was extensively metabolized. A  number of polar products, including 
one major peak with a  retention  time of 13-16 min, was produced from each mono- 
HETE.  HPLC  analyses  of the  radiolabel  recovered  from the  medium  showed  that 
after 2 h of incubation, 87.8 +  6.0% of 15-HETE, 79.2 +  0.5% of 12-HETE, and  100% 
of 5-HETE  (n ~- 2)  were converted to more polar metabolites.  Greater  than  98% of 
each HETE was recovered in unmodified form after incubation in the absence of cells 
(Fig.  2).  Cell  viabilities  of cultures exposed to  1-/~M concentrations of mono-HETEs 
for 2  h  always  remained  comparable  to control  cultures  exposed  to c~-MEM  alone N.  A.  PAWLOWSKI, W.  A.  SCOTT,  M.  ANDREACH,  AND  Z.  A.  COHN  1657 
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F16.  1.  (left)  HPLC chromatograms of all-labeled products in culture medium after incubation 
of resident macrophages with 0.5 #Ci of [all]20:4  (6.4 nM). A, 5 min; B,  10 min; and C, 60 min. 
Macrophages cultured for  16 h were washed with cold PD, overlaid with cold a-MEM containing 
[SH]20:4, and then incubated at 37°C fur the indicated periods of time. Media were extracted and 
subjected to HPLC using solvent system  1, as described in Materials and Methods. HPLC profiles 
of [SH]20:4 incubated in medium without cells for 60 rain showed that at least 90% of the recovered 
radiolabel was unreacted 20:4. 3H-labeled  6-keto  PGF~, PGF2,,  PGE2, and TXB2 elute at  4-11 
min;  mono-HETE standards elute at  30-50  rain,  and  20:4  elutes  at  70-75  min.  Macrophages 
incubated with I #M 20:4 generated polar metabolites with a similar percentage of conversion with 
time. 
Fic.  2.  (right)  HPLC chromatograms (  ) of polar metabolites produced by resident macro- 
phages after 2-h incubation with  l-/,tM concentrations of 15-(A), 12-(B), and 5-HETEs (C). (-- -) 
represent the chromatograms obtained after incubation of each respective mono-HETE in medium 
without cells for 2 h. Resident macrophages in culture for 16 h were washed with PD and incubated 
in c~-MEM containing each mono-HETE. After 2 h, the media were extracted and subjected to 
HPLC using solvent system  1, as described in Materials and Methods. Mono-HETE elution times 
vary with the HPLC column age, but the separation of individual mono-HETEs is not affected. 
The major polar metabolites of each HETE eluted at  13-16 rain. 
(~99%).  Likewise, the phagocytic capacities of cultures incubated  with  each  mono- 
HETE  (1/zM)  for 2  h  remained comparable to controls. 
Time-Course  of Mono-HETE  Metabolism.  The  time-course of mono-HETEs  metabo- 
lism was examined using 15-HETE (Fig. 3). The rate of  conversion to polar metabolites 
is  concentration dependent.  Approximately  50%  conversion was reached at  30  rain 
and 60  min, respectively, for 0.33-  and  1-#M  HETE.  Similar kinetics were observed 1658  MACROPHAGE  HYDROXY-EICOSATETRAENOIC ACID METABOLISM 
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F~c.  3.  (left)  Time-course of 15-tIETE metabolism by resident  macrophages.  16-h cultures of 
resident  macrophages  were incubated with either I #M (  ) or 0.33 FM (- - -) concentrations of 
15-HETE in a-MEM. At the indicated times, the incubation medium was extracted and subjected 
to ttPLC using solvent system  1, as described  in Materials and Methods.  Chromatographic data 
were analyzed for percentage conversion of radiolabel remaining in the medium to metabolites more 
polar than the native compound. The percent decrease in 15-HETE  (A) and the percent increase 
in total  polar metabolites (0)  recovered  from  the medium over time at each  concentration are 
presented.  A similar time-course  for  metabolism of 5-  and  12-HETEs  (l  ffM) was  found after 
incubation with resident macropbages. 
Fie.  4.  (right)  HPLC chromatograms and ultraviolet absorption spectra  of major mono-HETE 
metabolites generated  by  resident  macrophages.  A,  15-HETE;  B,  12-HETE;  and C,  5-HETE 
metabolites.  The major metabolites of 15-, 12-, and 5-t-IETEs isolated  by HPLC  using solvent 
system  1 (retention time 13-16 min, Fig. 2) were dried under reduced  pressure and rechromato- 
graphed using solvent system 2, as described in Materials and Methods. The insets to the right show 
the ultraviolet absorption spectra recorded in HPLC buffer for the major peak in each profile. 
for  the  conversion  of  1-/~M  12-  and  5-HETEs.  Resting  macrophages,  therefore, 
metabolize each mono-HETE  with a  time-course comparable to that  for the produc- 
tion of oxygenated metabolites from endogenous 20:4 (1). 
Rechromatography  of the  major  HETE  metabolites  generated  from  each  mono- 
HETE  (retention times,  13-16 min, Fig.  2), using solvent system  2, yielded a  single 
major  peak  of radioactivity,  as  shown  in  Fig.  4.  Retention  times  of the  products 
derived from each mono-HETE  differed slightly, and their elution order followed that 
of the three mono-HETEs  using solvent system  1 (Fig. 2). Additional smaller peaks of 
radioactivity separated  from each major peak after rechromatography,  but the major 
peak accounted for >75% of the total in each instance. 
Ultraviolet  absorption  spectra  were  obtained  for  each  of the  major  metabolites 
derived  from  mono-HETEs  (Fig.  4).  The  15-  and  12-HETE  products  retained  the 
spectral  characteristics  of the  original  HETEs  (single maxima  at  235-237  nm).  In 
contrast, the major 5-HETE metabolite had an ultraviolet spectrum with a  maximum N.  A.  PAWLOWSKI, W. A. SCOTT,  M.  ANDREACH, AND  Z.  A. COHN  1659 
at  268  nm  and  shoulders  at  258  and  278  nm,  indicating  the  presence  of  three 
conjugated double bonds (conjugated triene)  (12). 
Rechromatography of the other more polar metabolites (fractions 4-12,  Fig. 2) of 
15-,  12-, and  5-HETEs,  using solvent system  2,  indicated that  in  total,  10  or more 
individual metabolites are produced  from  each  mono-HETE  after incubation  with 
macrophages. 
Incorporation of Mono-HETEs into Cell Lipids.  Separate resting macrophage cultures 
were  incubated  with  1-btM  concentrations  of  15-,  12-,  or  5-HETEs.  After  2  h  of 
incubation,  ~12-30%  of the  recovered  radiolabel was  cell associated  (n  --  3).  The 
uptake of 5-HETE  tended to be greater than  that of the other mono-HETEs  tested 
(Table I). Kinetic studies indicated that maximum uptake occurred by ~30 rain for 
each HETE. 
Two-dimensional thin-layer chromatography of cell extracts indicated that 76-89% 
of the cell-associated radiolabel was incorporated into cellular lipid (n =  2).  Fig. 5 A 
shows the distribution of radiolabel among the various cell lipids. Each mono-HETE 
was  found  incorporated  primarily  into  phospholipid  (15-HETE,  83%;  12-HETE, 
71.6%;  and  5-HETE,  50%), with the remainder recovered in neutral lipid or as free 
fatty acid. 74.4% and 80.8% of the total phospholipid-associated radiolabel was found 
in phosphatidyleholine, the major macrophage phospholipid, after incubation with 5- 
and  12-HETEs,  respectively. Similar data  for  15-HETE  indicated that  73%  of the 
radiolabel in phospholipids was distributed nearly equally between phosphatidylcho- 
line  and  phosphatidylinositol.  In  spite  of these  variations,  this  general  pattern  of 
incorporation into phospholipids (particularly into phosphatidylcholine) is similar to 
that after incubation of macrophages with 20:4 in serum-free or in serum-containing 
medium  (1, 4). 
The uptake of the polar HETEs  metabolites by macrophages was also examined. 
Cultures were incubated with the total metabolites generated from  12-HETE after a 
2-h  incubation  with  macrophages  (fractions  4-30,  Fig.  2B).  Only  3%  of the  total 
radiolabel recovered was cell associated. HPLC  of the medium extracts revealed an 
elution profile identical to that before incubation. These results indicate that the polar 
TABLE  I 
Comparison of Resident and Activated Macrophage Uptake and Metabolism of Mono-HETEs 
15-HETE  12-HETE  5-HETE 
I.  Uptake* 
A. % in cells  12.4 zlz 7.8 (11.2+2.2)  14.3+3.4  (19.1 +0.2)  30.5+0.5  (69.0+3.0) 
B.  % in phospholipid  83.3  (27.5)  71.6  (37.7)  50.1  (15.8) 
II. Metabolism:l:  88  (17)  79  (27)  100  (65) 
All data are expressed as percent of total recovered. Data outside parentheses are derived from experiments 
with resident macrophages, and data inside are from C. parvum-elicited macrophages. 
* Maerophages were incubated with each mono-HETE  (1 ~M) in a-MEM for 2 h, as described in Materials 
and Methods. A, percent cell-associated radiolabel of the total recovered from medium and cells. Results 
are given for the percent uptake (mean :i: SEM) determined  from three to four replicate culture plates 
per experiment. The uptake of each mono-HETE  was tested in three separate experiments with resident 
macrophages  and one experiment  with activated macrophages.  B,  percent  cell-associated radiolabel 
recovered in phospholipids after incubation  with resident (n =  2) or activated (n =  1) macrophages, as 
described in Fig. 5. 
:~ Percent conversion of radiolabeled HETE (1/.tM) recovered from incubation medium to polar metabolites 
after incubation with resident (n = 2-3) and activated macrophages (n =  1), as described in Fig. 2. 1660  MACROPHAGE PtYDROXY-EICOSATETRAENOIC ACID METABOLISM 
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Fio.  5.  Incorporation of mono-HETEs into macrophage lipids. 15-, 12-, and 5-HETEs (1/tM) in 
a-MEM were incubated with resident (A) or C. parvum-elicited macrophages (B) for 2 h, as described 
in Fig. 2. Cell monolayers  were then washed, scraped into PD, and the lipids extracted. The extracts 
were then subjected to two-dimensional  thin layer chromatography, as described in Materials and 
Methods. Areas of ehromatograms containing lipid were scraped and the radioactivity of each was 
determined. Data are expressed as the percentage of the total recovered radiolabel. Each mono- 
HETE was tested in two experiments  with resident macrophages and one experiment with activated 
macrophages. PS, phosphatidylserine;  PI, phosphatidylinositol;  SPH, sphingomyelin;  PC,phospha- 
tidylcholine; PE, phosphatidylethanolamine; DPG, diphosphatidyl glycerol; NL, neutral  lipids; 
FFA, free fatty acids. 
metabolites, once formed, are neither incorporated nor metabolized further by mac- 
rophages. 
Uptake and Metabolism of Cyclooxygenase Products.  Resting macrophage cultures were 
incubated for  2  h  with  each  of four radiolabeled cyclooxygenase products  (PGE2, 
PGF2~, TXB2, and 6-keto PGFI~) under serum-free conditions. In each  instance, at 
least 95% of the added radiolabel was recovered from the medium at the end of the 
incubation period.  HPLC  analyses  of the  radiolabel  extracted  from  the  medium 
revealed that these products were not altered by exposure to macrophages. In contrast 
to  mono-HETEs, macrophages fail to either take  up or metabolize cyclooxygenase 
products. 
Metabolism and Uptake of Mono-HETEs by Activated Macrophages.  Previous studies (4) 
showed that exogenous 20:4 metabolism was reduced and that uptake was increased 
in cultures of activated macrophages. Similarly, the extent of mono-HETE metabo- 
lism was markedly diminished in cultures of C. parvum-activated  macrophages. 83%, 
73%, and 45% of 15-,  12-,  and 5-HETEs (1  /.tM)  were recovered unmodified after a 
2-h incubation with C. parvum-activated  macrophages (Table I). 
The uptake of 15- and 12-HETEs (11.2-19.2%) by C. parvum-activated macrophages 
was comparable to that by resident cells, whereas the incorporation of 5-HETE was N.  A.  PAWLOWSKI,  W.  A.  SCOTT,  M.  ANDREACH,  AND  Z.  A.  COHN  1661 
twofold greater (69%) than by resident macrophages (Table I). Most of the radiolabel 
recovered in lipid extracts of activated cells represented HETEs incorporated into cell 
lipids (71.3-80.5%). However, in contrast to resident cells, the cell-associated radiolabel 
in  these activated cells was  recovered predominantly  (51%,  47%,  and  65%  for  15-, 
12-, and 5-HETEs, respectively) in neutral lipid (Fig. 5B). 
Discussion 
Mouse peritoneal macrophages have the capacity to metabolize exogenously sup- 
plied  20:4  in  the absence of a  discernible trigger  (4).  In  this report, we show that 
substantial conversion of exogenous 20:4 to oxygenated metabolites occurs within  10 
min (Fig. 1). This contrasts with the 60-rain time-course for phospholipid-derived 20:4 
release and metabolism in response to an inflammatory stimulus, a setting in which 
the rate-limiting step appears to be the release of fatty acid  (1).  The metabolism of 
exogenously supplied 20:4 thus provides an estimate of the rate at which macrophages 
convert 20:4 to oxygenated metabolites. Within the experimental limits of detection 
and  within  the lethal tolerance of macrophages  for 20:4  (6.4  nM-1  gM),  we were 
unable to either saturate the reaction or estimate a rate-limiting concentration of fatty 
acid substrate. It is therefore evident that these ceils have a considerable capacity for 
the synthesis of cyclooxygenase and lipoxygenase products. 
As noted previously (4), the proportion (70%)  of exogenous 20:4 metabolized via 
the lipoxygenase pathway is considerably greater than from endogenous 20:4 stores 
(35%).  Mono-HETEs and polar lipoxygenase products other than leukotriene C  are 
the  predominant  metabolites  generated  from  20:4  in  the  culture  medium.  Mouse 
peritoneal  macrophages  synthesize  12-HETE  (17)  and  also  have  the  capacity  to 
produce leukotriene C, the major lipoxygenase product formed from endogenous 20:4 
after appropriate stimulation  (2-3). This indicates the presence of 12- and 5- lipoxy- 
genases. Although the individual mono-HETEs generated remain to be identified by 
mass spectrometric means, our results indicate the macrophage produces from exog- 
enous 20:4 at least two major products with chromatographic properties compatible 
with mono-HETEs. Two of these products (elution times, 34-35 and 38-39 rain; Fig. 
1) co-chromatograph with 15- and  12-HETE standards on reverse-phase HPLC. 
Macrophages  are  a  potent  source of 20:4  metabolites  derived  secondarily  from 
mono-HETEs. 5-, 12-, and 15-HETEs are readily converted to more polar derivatives 
by macrophages. These reactions are specific in that neither cyclooxygenase products 
(prostaglandins and thromboxane) nor polar products of mono-HETEs are metabol- 
ically altered. A  number of metabolic routes for related 20:4 metabolites have been 
described. Certain prostaglandins may undergo 8- or ~0-oxidation and ~0-hydroxylation 
(18).  Leukotriene B4 (LTB4; 5(S),  12(R)-dihydroxy-6,8,10,14-ds,  tram,  trans, cis-eicos- 
atetraenoic acid), a mediator of neutrophil chemotaxis and adherence to endothelium 
(19-20), has recently been shown to undergo ~0-hydroxylation and subsequent  con- 
version to  a  dicarboxylic acid  with  a  resulting change  in  its  spectrum  of biologic 
activity  (21).  Finally, sequential  oxygenation reactions  are  possible,  as  have  been 
shown  for  the  generation  of 5(S),  12(S)-dihydroxy-6,8,10,14-eicosatetraenoic acid 
[5(S), 12(S)-di-HETE] (22). 
Interestingly,  the  major  metabolite  generated  by  macrophages  from  5-HETE 
exhibits a triene spectrum with absorption maxima identical to that of 5(S), 12(S)-di- 
HETE (22). In addition, this compound has an elution time comparable to LTB4 on 1662  MACROPHAGE  HYDROXY-EICOSATETRAENOIC ACID METABOLISM 
reverse-phase HPLC  (N. A.  Pawlowski, unpublished  results)  as does 5(S),  12(S)-di- 
HETE, as shown by others (22-23). Taken together, these findings suggest that  the 
major metabolite of 5-HETE might arise from the introduction of a second hydroxyl 
group  at  position  12.  The  5-HETE  major  metabolite,  however,  did  not  elicit  a 
chemotactic response when tested with human neutrophils over a wide concentration 
range (maximum, 1 #M),  z indicating nonidentity with LTB4. The formation of 5(S), 
12(S)-di-HETE  has  previously  been  shown  with  neutrophils  incubated  with  20:4 
(100-150  #M)  in  the  presence  or  absence  of calcium  ionophore A23187  (22-23). 
Although biologic activity has been reported for this compound (22), its physiologic 
role remains undetermined. It should be noted that the major metabolites of 12- and 
15-HETEs generated by macrophages also  have chromatographic properties of di- 
HETEs. However, neither of these derivatives have a triene spectrum. In the case of 
the  12-HETE derivative, this suggests that  the second hydroxylation step does not 
occur at position 5. The structures and biological activities of these major metabolites 
of mono-HETEs are currently under investigation. 
In addition to metabolic conversion, macrophages incorporate mono-HETEs into 
cell lipid. This reaction is specific for mono-HETEs in that macrophages fail to take 
up  other  oxygenated derivatives of 20:4.  The  uptake  of mono-HETEs suggests  a 
possible  physiologic role  for these compounds  in  regulating  macrophage  function. 
This is emphasized by their predominant incorporation into phospholipid and pre- 
sumably cell membranes. Resting neutrophils likewise take up exogenously supplied 
mono-HETEs (24-25), but the extent of incorporation into phospholipids (22% and 
12.5% of the cell-associated 5- and  12-HETE) contrasts with the high percentage of 
mono-HETEs incorporated into macrophage phospholipid (50-83%). 
The reduced capacity of activated macrophages to metabolize each mono-HETE 
parallels the reduction in the generation of oxygenated metabolites from 20:4 in this 
cell  population  (5).  This  finding  suggests  that  inhibition  of lipoxygenase activity 
occurs as  a  result of macrophage activation in  addition  to the loss  of prostacyclin 
synthetase  (5)  and  specific  enzyme(s)  for  leukotriene  C  biosynthesis  (5).  Because 
oxidative metabolism and esterification are distinct fates of exogenous 20:4  (4), the 
enhanced incorporation of 20:4 into cell phospholipid exhibited by activated macro- 
phages  might  be  a  result  of this  diminished  metabolic  capacity.  It  is  surprising, 
therefore, that only the uptake of 5-HETE was increased in activated cells and that 
incorporation was  largely into neutral  lipid  rather than  phospholipid.  This might 
indicate that the mechanisms for esterification of 20:4 and HETEs are distinct, with 
the  latter controlled by the  activation state of the  macrophage.  Alternatively, the 
phospholipids of activated cells might be enriched with naturally occurring HETEs 
as a result of an in vivo phagocytic event causing the cell to shunt additional HETEs 
into neutral or storage lipid. 
Summary 
Within 5 rain, resting macrophages metabolize #M quantities of exogenous arach- 
idonic acid  (20:4)  to cyclooxygenase and lipoxygenase products. Mono-HETEs rep- 
resent a major class ofmetabolites recovered from the medium. However, the quantity 
of mono-HETEs  progressively decreases over a  60-min  incubation  period,  with  a 
concomitant  increase  in  more  polar  lipoxygenase products,  suggesting  additional 
2  The chemotactic  assay was kindly performed  by Dr. Eva Cramer. N.  A.  PAWLOWSKI, W.  A.  SCOTT,  M.  ANDREACH,  AND Z.  A.  COHN  1663 
metabolic  fates  for  these  hydroxy acids.  This  was  directly  confirmed  by  exposing 
resident macrophage cultures to radiolabeled  15-, 12-, and 5-HETEs (1 #M).  12-30% 
of  the  recovered  HETEs  were  cell-associated  and  predominantly  esterified  into 
phospholipid.  High  pressure  liquid  chromatography  analyses  of medium  extracts 
indicated that 50% of each HETE was also converted to 10 or more metabolites over 
a  60-min  time-course,  a  rate slower than  for 20:4. The major metabolite  generated 
from each mono-HETE had the elution characteristics of a  di-HETE. The 5-HETE 
product has a triene spectrum similar to that of 5(S),  12(S)-di-HETE, whereas the 15- 
and  12-HETE products exhibited single ultraviolet  absorption maxima, indicating a 
metabolic pathway  for 5-HETE  distinct  from the other mono-HETEs.  None of the 
stable cyclooxygenase products of 20:4 (6-keto PGFI,, PGF2,, PGE2, TXB2) nor polar 
metabolites  of mono-HETEs  are  either  incorporated  or  metabolized.  The  results 
indicate  that  macrophages  have  the  capacity  to  specifically  metabolize  20:4  and 
mono-HETEs to polar oxygenated products in the absence of a  discernible trigger. 
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